PubMed:33115909
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 44-52 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 70-117 | Disease | denotes | Severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 119-127 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T4 | 502-510 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 735-743 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 878-886 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 999-1007 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 1244-1252 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 1414-1422 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 134-135 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 211-212 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 355-356 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 401-406 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T5 | 615-616 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 733-734 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T7 | 895-896 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 1110-1120 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T9 | 1177-1178 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1 | 44-54 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
13 | 70-117 | Species | denotes | Severe acute respiratory syndrome coronavirus 2 | Tax:2697049 |
14 | 119-129 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
15 | 136-153 | Species | denotes | novel coronavirus | Tax:2697049 |
16 | 401-406 | Species | denotes | human | Tax:9606 |
17 | 502-512 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
18 | 633-645 | Species | denotes | participants | Tax:9606 |
19 | 735-745 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
20 | 878-888 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
21 | 999-1009 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
22 | 1244-1254 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
23 | 1414-1422 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-55 | Sentence | denotes | Will vaccination refusal prolong the war on SARS-CoV-2? |
T2 | 56-69 | Sentence | denotes | INTRODUCTION: |
T3 | 70-264 | Sentence | denotes | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that appeared in Wuhan, China in January 2020 and caused a global pandemic drastically changing everyday life. |
T4 | 265-411 | Sentence | denotes | Currently, there are vaccine candidates in clinical trials and development, so it is only a matter of time before one is authorised for human use. |
T5 | 412-434 | Sentence | denotes | MATERIALS AND METHODS: |
T6 | 435-568 | Sentence | denotes | We collected public opinion survey results about attitudes towards SARS-CoV-2 vaccination conducted in 2020 in 26 European countries. |
T7 | 569-577 | Sentence | denotes | RESULTS: |
T8 | 578-889 | Sentence | denotes | The pooled surveys were conducted on a total of 24 970 participants; on average only 58% (n=14 365/24 970) of responders across Europe were willing to get a SARS-CoV-2 vaccine once it becomes available, 16% (n=3998/24 970) were neutral, and 26% (n=6607/24 970) were not planning to vaccinate against SARS-CoV-2. |
T9 | 890-1030 | Sentence | denotes | Such a low vaccination response could make it exceedingly difficult to reach the herd immunity threshold for SARS-CoV-2 through vaccination. |
T10 | 1031-1042 | Sentence | denotes | CONCLUSION: |
T11 | 1043-1267 | Sentence | denotes | It is very important to start conducting educational public health activities on the topic of vaccination as soon as possible, before a vaccine becomes available, in order to improve attitudes towards SARS-CoV-2 vaccination. |
T12 | 1268-1432 | Sentence | denotes | Only by educating the general public about the benefits, safety and efficacy of vaccines can we hope to avoid the unnecessary prolongation of the COVID-19 pandemic. |